Christopher J. Coughlin
Christopher J. Coughlin is on the board of Alexion Pharmaceuticals, Inc., Prestige Consumer Healthcare, Inc. and Karuna Therapeutics, Inc. Mr. Coughlin previously occupied the position of Chief Operating Officer, Director & Executive VP at Interpublic Group of Cos., Inc., Director at Dun & Bradstreet Corp., President of Nabisco International, Inc., Chief Financial Officer & Executive Vice President at Tyco International Ltd., Chief Financial Officer for Sterling Winthrop, Inc., Chief Financial Officer & Executive Vice President of Pharmacia Corp., Chief Financial Officer & Executive Vice President at Nabisco Holdings Corp. and President-International at Nabisco Group Holdings Corp.
He received an undergraduate degree from Boston College.
Transactions
Date
Transaction
Value
| 05/14/2020 | 2,774 | Award at $0 per share. | 0 |
| 05/14/2020 | 3,468 | Award at $0 per share. | 0 |
| 05/15/2019 | 2,181 | Award at $0 per share. | 0 |
| 05/15/2019 | 2,726 | Award at $0 per share. | 0 |
| 05/09/2018 | 2,174 | Award at $0 per share. | 0 |
| 04/30/2018 | 10,000 | Acquisition at $120.79 per share. | 1,207,900 |
| 12/05/2017 | 10,000 | Award at $112.75 per share. | 1,127,500 |
| 06/15/2017 | 2,000 | Acquisition at $117.1 per share. | 234,200 |
| 05/10/2017 | 2,030 | Award at $0 per share. | 0 |
| 05/11/2016 | 835 | Award at $0 per share. | 0 |
